Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Drug therapy for multiple sclerosis.
FDA Approves New Drug to Treat Psoriasis
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
Assessing spinal cord function in multiple sclerosis with functional neuroimaging: insights and limitations.
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis.
Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports.
Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
Multiple sclerosis: TNF receptor 1 gene variant could explain failure of TNF-blocking drugs in multiple sclerosis.
2014 multiple sclerosis therapeutic update.
Biointegrator announced that it has successfully launched Neskler® - a first generic of Gilenya® in Russia and EuroAsian Economic Union
Magnetic resonance elastography reveals altered brain viscoelasticity in experimental autoimmune encephalomyelitis.
Demyelination and other neurological adverse events after anti-TNF therapy.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.
Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality.
Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.
The visual pathway as a model to understand brain damage in multiple sclerosis.
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).
Teriflunomide for oral therapy in multiple sclerosis.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis.

Pages